Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine

Sadek, Safiyah M.; Khatri, Shailesh N.; Kipp, Zachary; Dunn, Kelly E.; Beckmann, Joshua S.; Stoops, William W.; Hinds, Terry D.; Gipson, Cassandra D.

doi:10.1016/j.neuropharm.2023.109816

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine

Cited by 5 publications

References 52 publications

Xylazine does not enhance fentanyl reinforcement in rats: A behavioral economic analysis

Xylazine does not enhance fentanyl reinforcement in rats: A behavioral economic analysis

Effects of xylazine on naloxone-precipitated fentanyl withdrawal in male and female rats

Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options

Contact Info

Product

Resources

About